EPIGENOMIC PROGRAMMING

Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases; Pharmaceutical agents affecting DNA structure and/or epigenomic state by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, CNS disorders